TRANSPLANT GENOMICS APPROVED AS MEDI-CAL PARTICIPATING PROVIDERErica Gifford2023-12-11T10:55:06-05:00December 2023|Read More
TRANSPLANT GENOMICS RECEIVES GEISINGER HEALTH PLAN COVERAGE FOR TRUGRAF AND VIRACOR TRAC KIDNEY TESTSErica Gifford2023-11-06T11:21:55-05:00October 2023|Read More
Third Circuit Court of Appeals Affirms Judgment in Favor of Eurofins Viracor in Patent Infringement CaseJason Laffer2022-08-01T21:39:58-04:00July 2022|Read More
Transplant Genomics Welcomes Chief Medical Officer Jon Friedman, MD, FASTTruGraf2022-02-02T16:02:23-05:00February 2022|Read More
AJT Article Validates Clinical Utility of Donor-Derived Cell-Free DNA in Detecting Liver RejectionTruGraf2021-11-01T17:43:59-04:00November 2021|Read More
CJASN Publishes Study Validating the Combination of Biomarkers for Improved Detection of Kidney RejectionTruGraf2021-11-01T17:43:19-04:00November 2021|Read More
Eurofins Transplant Genomics Enrolls 500th Patient in TRULO Observational StudyTruGraf2021-11-01T17:42:30-04:00November 2021|Read More
Eurofins Transplant Genomics Announces 2021-2022 Scientific Advisory BoardTruGraf2021-09-22T10:50:08-04:00August 2021|Read More
TruGraf Contracted with Humana for In-Network Coverage of Medicare Kidney Transplant PatientsTruGraf2021-09-22T10:50:35-04:00July 2021|Read More
Eurofins Transplant Diagnostics Group Receives New York State CLEP Approval for Novel Rejection Biomarker AssaysTruGraf2021-09-22T10:58:25-04:00April 2021|Read More